Literature DB >> 26286886

Activation of Hsp90 Enzymatic Activity and Conformational Dynamics through Rationally Designed Allosteric Ligands.

Sara Sattin1, Jiahui Tao2, Gerolamo Vettoretti3, Elisabetta Moroni3, Marzia Pennati4, Alessia Lopergolo4, Laura Morelli1, Antonella Bugatti5, Abbey Zuehlke6, Mike Moses6, Thomas Prince6, Toshiki Kijima6, Kristin Beebe6, Marco Rusnati5, Len Neckers6, Nadia Zaffaroni4, David A Agard2, Anna Bernardi1, Giorgio Colombo7.   

Abstract

Hsp90 is a molecular chaperone of pivotal importance for multiple cell pathways. ATP-regulated internal dynamics are critical for its function and current pharmacological approaches block the chaperone with ATP-competitive inhibitors. Herein, a general approach to perturb Hsp90 through design of new allosteric ligands aimed at modulating its functional dynamics is proposed. Based on the characterization of a first set of 2-phenylbenzofurans showing stimulatory effects on Hsp90 ATPase and conformational dynamics, new ligands were developed that activate Hsp90 by targeting an allosteric site, located 65 Å from the active site. Specifically, analysis of protein responses to first-generation activators was exploited to guide the design of novel derivatives with improved ability to stimulate ATP hydrolysis. The molecules' effects on Hsp90 enzymatic, conformational, co-chaperone and client-binding properties were characterized through biochemical, biophysical and cellular approaches. These designed probes act as allosteric activators of the chaperone and affect the viability of cancer cell lines for which proper functioning of Hsp90 is necessary.
© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Hsp90; allostery; drug design; functional dynamics; glycoconjugates

Mesh:

Substances:

Year:  2015        PMID: 26286886      PMCID: PMC5921052          DOI: 10.1002/chem.201502211

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  54 in total

1.  Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes.

Authors:  Richard A Friesner; Robert B Murphy; Matthew P Repasky; Leah L Frye; Jeremy R Greenwood; Thomas A Halgren; Paul C Sanschagrin; Daniel T Mainz
Journal:  J Med Chem       Date:  2006-10-19       Impact factor: 7.446

2.  Enforced N-domain proximity stimulates Hsp90 ATPase activity and is compatible with function in vivo.

Authors:  Lester Pullen; Daniel N Bolon
Journal:  J Biol Chem       Date:  2011-01-28       Impact factor: 5.157

3.  Turning enzymes ON with small molecules.

Authors:  Julie A Zorn; James A Wells
Journal:  Nat Chem Biol       Date:  2010-03       Impact factor: 15.040

Review 4.  HSP90 and the chaperoning of cancer.

Authors:  Luke Whitesell; Susan L Lindquist
Journal:  Nat Rev Cancer       Date:  2005-10       Impact factor: 60.716

5.  Substrate binding drives large-scale conformational changes in the Hsp90 molecular chaperone.

Authors:  Timothy O Street; Laura A Lavery; David A Agard
Journal:  Mol Cell       Date:  2011-04-08       Impact factor: 17.970

6.  Asymmetric Hsp90 N domain SUMOylation recruits Aha1 and ATP-competitive inhibitors.

Authors:  Mehdi Mollapour; Dimitra Bourboulia; Kristin Beebe; Mark R Woodford; Sigrun Polier; Anthony Hoang; Raju Chelluri; Yu Li; Ailan Guo; Min-Jung Lee; Elham Fotooh-Abadi; Sahar Khan; Thomas Prince; Naoto Miyajima; Soichiro Yoshida; Shinji Tsutsumi; Wanping Xu; Barry Panaretou; William G Stetler-Stevenson; Gennady Bratslavsky; Jane B Trepel; Chrisostomos Prodromou; Len Neckers
Journal:  Mol Cell       Date:  2014-01-23       Impact factor: 17.970

7.  Heat shock protein 90 in neurodegenerative diseases.

Authors:  Wenjie Luo; Weilin Sun; Tony Taldone; Anna Rodina; Gabriela Chiosis
Journal:  Mol Neurodegener       Date:  2010-06-03       Impact factor: 14.195

Review 8.  Hsp90 and co-chaperones twist the functions of diverse client proteins.

Authors:  Abbey Zuehlke; Jill L Johnson
Journal:  Biopolymers       Date:  2010-03       Impact factor: 2.505

9.  Uncovering a region of heat shock protein 90 important for client binding in E. coli and chaperone function in yeast.

Authors:  Olivier Genest; Michael Reidy; Timothy O Street; Joel R Hoskins; Jodi L Camberg; David A Agard; Daniel C Masison; Sue Wickner
Journal:  Mol Cell       Date:  2012-12-20       Impact factor: 17.970

10.  Posttranslational modification and conformational state of heat shock protein 90 differentially affect binding of chemically diverse small molecule inhibitors.

Authors:  Kristin Beebe; Mehdi Mollapour; Bradley Scroggins; Chrisostomos Prodromou; Wanping Xu; Mari Tokita; Tony Taldone; Lester Pullen; Bettina K Zierer; Min-Jung Lee; Jane Trepel; Johannes Buchner; Daniel Bolon; Gabriela Chiosis; Leonard Neckers
Journal:  Oncotarget       Date:  2013-07
View more
  25 in total

Review 1.  Adapting to stress - chaperome networks in cancer.

Authors:  Suhasini Joshi; Tai Wang; Thaís L S Araujo; Sahil Sharma; Jeffrey L Brodsky; Gabriela Chiosis
Journal:  Nat Rev Cancer       Date:  2018-09       Impact factor: 60.716

Review 2.  In Silico Studies in Drug Research Against Neurodegenerative Diseases.

Authors:  Farahnaz Rezaei Makhouri; Jahan B Ghasemi
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

Review 3.  Investigating Cryptic Binding Sites by Molecular Dynamics Simulations.

Authors:  Antonija Kuzmanic; Gregory R Bowman; Jordi Juarez-Jimenez; Julien Michel; Francesco L Gervasio
Journal:  Acc Chem Res       Date:  2020-03-05       Impact factor: 22.384

4.  Molecular insights into the interaction of Hsp90 with allosteric inhibitors targeting the C-terminal domain.

Authors:  Vasantha Kumar Mv; Radwan Ebna Noor; Rachel E Davis; Zheng Zhang; Edvinas Sipavicius; Dimitra Keramisanou; Brian S J Blagg; Ioannis Gelis
Journal:  Medchemcomm       Date:  2018-07-02       Impact factor: 3.597

5.  Synthesis and evaluation of a ring-constrained Hsp90 C-terminal inhibitor that exhibits neuroprotective activity.

Authors:  Zheng Zhang; Zhenyuan You; Rick T Dobrowsky; Brian S J Blagg
Journal:  Bioorg Med Chem Lett       Date:  2018-03-26       Impact factor: 2.823

6.  Synthesis and Biological Evaluation of Novobiocin Core Analogues as Hsp90 Inhibitors.

Authors:  Katherine M Byrd; Chitra Subramanian; Jacqueline Sanchez; Hashim F Motiwala; Weiya Liu; Mark S Cohen; Jeffrey Holzbeierlein; Brian S J Blagg
Journal:  Chemistry       Date:  2016-04-01       Impact factor: 5.236

7.  Synthesis and Biological Evaluation of Stilbene Analogues as Hsp90 C-Terminal Inhibitors.

Authors:  Katherine M Byrd; Caitlin N Kent; Brian S J Blagg
Journal:  ChemMedChem       Date:  2017-11-30       Impact factor: 3.466

8.  Effects of Inhibitors on Hsp90's Conformational Dynamics, Cochaperone and Client Interactions.

Authors:  Sonja Schmid; Markus Götz; Thorsten Hugel
Journal:  Chemphyschem       Date:  2018-05-25       Impact factor: 3.102

9.  Design of Allosteric Stimulators of the Hsp90 ATPase as New Anticancer Leads.

Authors:  Ilda D'Annessa; Sara Sattin; Jiahui Tao; Marzia Pennati; Carlos Sànchez-Martìn; Elisabetta Moroni; Andrea Rasola; Nadia Zaffaroni; David A Agard; Anna Bernardi; Giorgio Colombo
Journal:  Chemistry       Date:  2017-03-22       Impact factor: 5.236

10.  Machine Learning Prediction of Allosteric Drug Activity from Molecular Dynamics.

Authors:  Filippo Marchetti; Elisabetta Moroni; Alessandro Pandini; Giorgio Colombo
Journal:  J Phys Chem Lett       Date:  2021-04-12       Impact factor: 6.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.